Recent Company News

• 01:16 PM ET Dec 24, 2025
  

  CMS announces that MACs are withdrawing the LCDs for certain skin substitutes

• 07:58 AM ET Dec 19, 2025
  

  FDA grants orphan drug designation to OncoC4 for gotistobart to treat squamous NSCLC ($91.46, 0.00)

• 08:53 AM ET Dec 16, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:54 AM ET Dec 18, 2025
  

  BioNTech closes acquisition of CureVac; 86.75% of CureVac shares tendered ($4.13, 0.00)

• 06:13 PM ET Dec 15, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 11:21 AM ET Dec 16, 2025
  

  FDA's Makary now says agency doesn't plan to put black box warnings on COVID-19 vaccines -- Bloomberg (yesterday post-close)

• 04:32 PM ET Dec 15, 2025
  

  CMS comments on the upcoming update to Final LCDs for certain skin substitutes

• 09:32 AM ET Dec 15, 2025
  

  Advisory Commission on Childhood Vaccines (ACCV) will meet 4X on 29-Dec